Phase I/II FIH Study of 9MW2921 in Patients With Advanced Solid Tumors

NCT05990452 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

261

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: 9MW2921

Sponsor

Mabwell (Shanghai) Bioscience Co., Ltd.